COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,637 Articles (22,913 medRxiv, 8,724 bioRxiv)

Most recent first Previous |  Page 11: Articles 101-110  | Next

Antioxidant properties of Rhodiola rosea
Brink, D. F., Sapp, T. L., Ghafoor, T. S., Boyland, P. A., Tamazawa, Y. C., Kaur, G., Shults, N. V., Sullivan, R. D., Suzuki, Y. J.
10.64898/2026.05.21.726678 — Posted: 2026-05-22
Sexually Transmitted and Bloodborne Infections, Methamphetamine Use, and COVID-19 Vaccination in Manitoba, Canada: A Retrospective Matched Cohort Analysis Using Population-Based Administrative Healthcare Data (2020-2022)
Shaw, S. Y. Y., Mahar, A., Bailey, K., Payne, M., Kindrachuk, J., Kelly, C., Friesen, K. J., Bernstein, C. N., Reimer, J., Becker, M. L., McClarty, L. M., Stein, D., Nickel, N. C.
10.64898/2026.05.18.26353507 — Posted: 2026-05-21
The control gap in long COVID research: a meta-epidemiological analysis
Panagiotopoulos, A.-P., Laskaris, A., Tsakri, D., Manoussopoulos, Y., Anastassopoulou, C., Tsakris, A., Ioannidis, J.
10.64898/2026.05.16.26353381 — Posted: 2026-05-21
Predicting Functional Changes in Down Syndrome During the COVID-19 Pandemic: The Role of Biopsychosocial Determinants of Health
Jo, E., Wall, C., Allen, L. K., Wheeler, N., Baumer, N., D'Aguilar, A., York, T. P., Capone, G., Jackson-Cook, C., Amstadter, A. B., Brown, R. C.
10.64898/2026.05.19.26353577 — Posted: 2026-05-21
Spike antibodies targeting GRP78 predispose to cardiovascular complications compared to Dengue
Sarker, S., Roy, T., Mallick, A., Das, S., Teja, S. D., Bandyopadhyay, A., Gorai, S., De, A., Biswas, S.
10.64898/2026.05.20.726568 — Posted: 2026-05-21
Ribophorin-1 Governs Spike Abundance of Highly Pathogenic Coronaviruses by ER-associated degradation
Huang, Y.-J., Lv, L., Ran, W., Zhao, H., Deng, Y.-Q., Ye, Q., Li, L., Wu, X.-Y., Chen, Q., Hu, Y., Sun, B., Zhao, J.-J., Zhao, J., Qin, C.
10.64898/2026.05.20.726704 — Posted: 2026-05-21
Occupational hierarchy, racialization, and COVID-19 health outcomes among meat processing plant workers in Alberta: a community-engaged mixed-methods study
Essar, M. Y., Norrie, E., Cerino, E. R., Antonio, M., Saad, A., Yemane, M., Holdbrook, L., Sahilie, A., Youssef, M., Hassan, N., Magwood, O., Edwards, S. T., Spitzer, D., Coakley, A., Pottie, K., Fabreau, G. E.
10.64898/2026.05.14.26353257 — Posted: 2026-05-20
Exploring the genetic architecture of multimorbidity and its impact on long COVID risk
Bauer, S. J. M., Bowyer, R. C. E., Bravo Merodio, L., Gkoutos, G., Vetrano, D., Jackson, T., Freidin, M. B., Steves, C. J.
10.64898/2026.05.18.26353402 — Posted: 2026-05-20
The Potential Clinical and Economic Impact of a Combination COVID-19 and Influenza Vaccine (mRNA-1083) in Canada
Fust, K., Kohli, M., Cartier, S., Van de Velde, N., Mehta, D., Blake, M.
10.64898/2026.05.18.26353482 — Posted: 2026-05-20
Mechanochemical Decoupling of ATP Hydrolysis and RNA Translocation in SARS-CoV-2 nsp13 by the L405D Mutation
Fazelpour, E., Roy, P., Frederick, K., McCullagh, M.
10.64898/2026.05.18.726016 — Posted: 2026-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).